Skip to main content
Premium Trial:

Request an Annual Quote

EMD Chemicals, MitoSciences to Co-develop Assays

NEW YORK (GenomeWeb News) – Merck KGaA subsidiary EMD Chemicals yesterday said that it will work with MitoSciences to develop assays for drug toxicity and mitochondrial bioactivity.

The firms intend to co-develop multiplex immunoassay products for EMD's WideScreen BeadPlex assay platform for detecting and profiling mitochondrial toxicity and activity. The WideScreen assays run on a Luminex xMAP system.

Under the agreement, MitoSciences has granted EMD exclusive tights to a family of monoclonal antibodies used for monitoring mitochondrial activity and bioactivity. MitoSciences also will work with EMD to validate the WideScreen assays for use in drug screening applications.

"To develop safer drugs and save time and resources in the process, the evaluation of toxicity is a clear focus in pre-clinical drug development," Christina Shasserre, VP and head of global biosciences for Merck KGaA and EMD Chemicals, said in a statement. "Testing the effect of drug candidates on mitochondrial processes such as metabolism and replication is as an important aspect of toxicity profiling."

The firms expect to launch the first set of assays in early 2010, targeting the pharmaceutical, biotech, and academic research markets.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.